Market capitalization | €812.31m |
Enterprise Value | €965.95m |
P/E (TTM) P/E ratio | 6.98 |
EV/FCF (TTM) EV/FCF | 7.05 |
EV/Sales (TTM) EV/Sales | 0.29 |
P/S ratio (TTM) P/S ratio | 0.24 |
P/B ratio (TTM) P/B ratio | 0.56 |
Dividend yield | 4.16% |
Last dividend (FY23) | €1.80 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
6 Analysts have issued a Drägerwerk forecast:
6 Analysts have issued a Drägerwerk forecast:
Jun '24 |
+/-
%
|
||
Revenue | 3,362 3,362 |
3%
3%
|
|
Gross Profit | 1,466 1,466 |
6%
6%
|
|
EBITDA | 310 310 |
40%
40%
|
EBIT (Operating Income) EBIT | 167 167 |
119%
119%
|
Net Profit | 116 116 |
184%
184%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.